Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis
NCT02780167
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
269
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
PF-04965842
DRUG:
PF-04965842
DRUG:
PF-04965842
DRUG:
PF-04965842
DRUG:
Placebo
Sponsor
Pfizer